Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Factor VII Antikörper (C-Term)

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch Factor VII in WB. Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN3042925

Kurzübersicht für Factor VII Antikörper (C-Term) (ABIN3042925)

Target

Alle Factor VII (F7) Antikörper anzeigen
Factor VII (F7) (Coagulation Factor VII (F7))

Reaktivität

  • 55
  • 11
  • 8
  • 5
  • 2
  • 2
  • 2
  • 1
  • 1
Human

Wirt

  • 51
  • 12
  • 8
  • 2
  • 1
Kaninchen

Klonalität

  • 63
  • 11
Polyklonal

Konjugat

  • 48
  • 15
  • 4
  • 3
  • 2
  • 1
  • 1
Dieser Factor VII Antikörper ist unkonjugiert

Applikation

  • 57
  • 27
  • 23
  • 18
  • 17
  • 7
  • 5
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB)
  • Bindungsspezifität

    • 6
    • 5
    • 4
    • 4
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 441-453, C-Term

    Verwendungszweck

    Anti-Factor VII/F7 Antibody Picoband®

    Sequenz

    SQYIEWLQKL MRS

    Kreuzreaktivität (Details)

    No cross-reactivity with other proteins

    Produktmerkmale

    Rabbit IgG polyclonal antibody for Coagulation factor VII(F7) detection. Tested with WB in Human.
    Gene Name: coagulation factor VII(serum prothrombin conversion accelerator)
    Protein Name: Coagulation factor VII

    Aufreinigung

    Immunogen affinity purified.

    Immunogen

    A synthetic peptide corresponding to a sequence at the C-terminus of human Factor VII.

    Isotyp

    IgG
  • Applikationshinweise

    Western blot, 0.1-0.5 μg/mL, Human
    1. Di Bitondo, R., Hall, A. J., Peake, I. R., Iacoviello, L., Winship, P. R. Oestrogenic repression of human coagulation factor VII expression mediated through an oestrogen response element sequence motif in the promoter region. Hum. Molec. Genet. 11: 723-731, 2002. 2. Millar, D. S., Kemball-Cook, G., McVey, J. H., Tuddenham, E. G. D., Mumford, A. D., Attock, G. B., Reverter, J. C., Lanir, N., Parapia, L. A., Reynaud, J., Meili, E., von Felton, A., Martinowitz, U., Prangnell, D. R., Krawczak, M., Cooper, D. N. Molecular analysis of the genotype-phenotype relationship in factor VII deficiency. Hum. Genet. 107: 327-342, 2000. 3. Zur, M., Nemerson, Y. Tissue factor pathways of blood coagulation.In: Bloom, A. L., Thomas, D. P. : Haemostasis and thrombosis. Edinburgh: Churchill Livingstone (pub.) 1981.

    Kommentare

    Antibody can be supported by chemiluminescence kit ABIN921124 in WB.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.

    Konzentration

    500 μg/mL

    Buffer

    Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Thimerosal, 0.05 mg Sodium azide.

    Konservierungsmittel

    Thimerosal (Merthiolate), Sodium azide

    Vorsichtsmaßnahmen

    This product contains Thimerosal (Merthiolate) and Sodium azide: POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.

    Handhabung

    Avoid repeated freezing and thawing.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store at -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
    It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freeze-thaw cycles.

    Haltbarkeit

    12 months
  • Target

    Factor VII (F7) (Coagulation Factor VII (F7))

    Andere Bezeichnung

    F7

    Hintergrund

    Synonyms: Coagulation factor VII,3.4.21.21,Proconvertin,Serum prothrombin conversion accelerator,SPCA,Eptacog alfa,Factor VII light chain,Factor VII heavy chain,F7,

    Tissue Specificity: Plasma.

    Background: F7 (Coagulation Factor VII), also known as proconvertin, is one of the proteins that causes blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. The F7 gene maps to chromosome 13q34 (Millar et al., 2000). Synthesis of factors VII and X, as well as factors II and IX, takes place in the liver and requires vitamin K. Structural homologies of these factors, which are precursors of serine proteases, have been shown (Zur and Nemerson, 1981). Di Bitondo et al. (2002) used reporter gene analysis to show that inclusion of promoter regions of F7 reduced transcription activity in the presence of estrogenic factors. The effect was independent of promoter polymorphic haplotype.

    Sequence Similarities: Belongs to the peptidase S1 family.

    Molekulargewicht

    52 kDa

    UniProt

    P08709

    Pathways

    Response to Growth Hormone Stimulus, Platelet-derived growth Factor Receptor Signaling
Sie sind hier:
Chat with us!